You are viewing: UK Blood Glucose Monitor Market analysis
Part of: Blood Glucose Monitor Market (Global)

The UK Blood Glucose Monitor Market was valued at $299.9 Million in 2025 and projected to reach to $413.9 Million by 2030, representing a compound annual growth rate of 6.7%. The UK blood glucose monitor market is positioned for sustained growth through 2030, driven by an aging population with increasing diabetes incidence and NHS prioritization of digital health solutions.

UK Blood Glucose Monitor Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Blood Glucose Monitor Market Trends and Insights

  • The UK market is driven by rising diabetes prevalence, increasing adoption of continuous glucose monitoring (CGM) devices, and growing NHS investment in digital health solutions.
  • The UK's aging population and emphasis on preventive care are key factors supporting market expansion during the 2025–2030 forecast period. In the UK, the shift toward home-based monitoring and remote patient management is reshaping the blood glucose monitor landscape.
  • The UK healthcare system's integration of advanced glucose monitoring technologies into standard diabetes care protocols is accelerating adoption among both Type 1 and Type 2 diabetes patients.
  • The UK market benefits from strong regulatory frameworks, established reimbursement pathways, and a digitally engaged patient population, positioning it as a mature yet growing segment within the European blood glucose monitor market..

Key Market Statistics

  • CAGR (2025-2030) 6.7% CAGR
  • Market Size, 2025 ~USD 299.9 Million
  • Forecast, 2030 ~USD 413.9 Million
  • Country UK

UK Blood Glucose Monitor Market Overview

Market Valuation :

The UK blood glucose monitor market is valued at £299.9 million in 2025 and is projected to reach £413.9 million by 2030, demonstrating steady growth in the healthcare technology sector.

Rising Diabetes Prevalence :

The UK's growing diabetes population, including both Type 1 and Type 2 cases, is driving increased demand for blood glucose monitoring devices across NHS trusts and private healthcare providers.

CGM Device Adoption :

Continuous glucose monitoring (CGM) technology is gaining significant traction in the UK market, supported by NHS funding initiatives and improved patient outcomes, particularly among Type 1 diabetes patients.

Digital Health Investment :

NHS digital health initiatives and government investment in remote patient monitoring are accelerating the adoption of connected glucose monitoring solutions across the UK healthcare system.

UK Blood Glucose Monitor Market Dynamics

  • Continuous glucose monitoring devices are expected to capture a larger market share as reimbursement policies expand and patient awareness grows.
  • The integration of AI-powered analytics and smartphone connectivity will enhance disease management capabilities.
  • Additionally, NHS commitment to preventive care and early diabetes detection will create new opportunities for glucose monitoring adoption across primary and secondary care settings throughout the United Kingdom..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK blood glucose monitor market is valued at £299.9 million in 2025 and will reach £413.9 million by 2030, growing at a 6.7% CAGR.
    • The UK market is driven by rising diabetes prevalence, NHS digital health investments, and increasing adoption of continuous glucose monitoring (CGM) devices.
    • The UK's mature healthcare infrastructure and established reimbursement pathways support steady market growth and technology adoption.
    • The UK market benefits from an aging population and strong emphasis on preventive care, positioning it as a key growth segment in Europe.

    Blood Glucose Monitor Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment NON-INVASIVE PRODUCTS (Product Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 9.1% from 2025 to 2030
    Largest Segment DIABETES MANAGEMENT (Application)
    Market Size Base Year (Billions) ~USD 16.44 (2025)
    Revenue Forecast (Billions) ~USD 25.41 (2030)
    Segments Covered Product Type, Type, Test Site, Application, End User

    UK Blood Glucose Monitor Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product Type

    • Continuous Glucose Monitoring Systems
    • Non-Invasive Products
    • Professional Point-Of-Care Devices
    • Self-Monitoring Blood Glucose Systems

    By Type

    • Glucometers
    • Implants
    • Lancets & Lancing Devices
    • Sensors
    • Testing Strips
    • Transmitters & Receivers
    • Type 1 Diabetes
    • Type 2 Diabetes

    By Test Site

    • Fingertip
    • Other Test Sites
    • Upper Arm

    By Application

    • Diabetes Management
    • Health & Wellness Monitoring
    • Other Applications

    By End User

    • Hospitals & Clinics
    • Other End Users
    • Self/Home Care

    UK: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    HOSPITALS & CLINICS76.278.280.782.48689.192.696.33.6
    OTHER END USERS45.648.251.253.757.761.565.870.46.6
    SELF/HOME CARE509.2544.9586.9625680.2735.6797865.48.1
    TOTAL631671.2718.8761.1823.9886.2955.31032.17.5

    Target Audience

    • Medical Device Manufacturers : Manufacturers need UK market intelligence to develop localized product strategies, understand NHS procurement requirements, and identify opportunities for CGM and glucose monitoring device launches.
    • Healthcare Investors & PE Firms : Investors require detailed UK market data to evaluate acquisition targets, assess growth potential in digital health, and make informed funding decisions in the diabetes care technology sector.
    • NHS Procurement Teams : NHS trusts and procurement departments need market analysis to benchmark pricing, evaluate supplier options, and optimize budget allocation for glucose monitoring solutions across regions.
    • Digital Health Startups : UK-based health tech startups need market sizing and trend analysis to validate business models, secure funding, and develop competitive offerings in the connected glucose monitoring space.
    • Pharmaceutical & Diabetes Care Companies : Pharma companies require UK-specific market insights to align glucose monitoring strategies with diabetes treatment portfolios and identify partnership opportunities with device manufacturers.

    Key Companies in the UK Blood Glucose Monitor Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospitals (LTACHs) – drug-intensive episodes,Inpatient rehabilitation facilities (IRFs) – rehab with chronic comorbidities,Contract rehabilitation and ancillary services,
    ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices,Diagnostic Products,Nutritional Products,
    DEXCOM, INC.United StatesPublic CompanyDexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE and ONE+,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
    SINOCAREChinaPublic CompanyBlood glucose monitoring systems and strips,Blood pressure and multiparameter testing devices,Hospital and primary healthcare diagnostic solutions,
    I-SENS, INC.South KoreaPublic CompanyBlood glucose meters and strips (human),POCT systems (blood gas, electrolytes, coagulation),Veterinary diagnostics,
    NIPROJapanPublic CompanyDialysis products and services,Injection and infusion / hospital disposables,Pharmaceuticals (generics and kits),
    NEMAURA MEDICAL INC.United StatesPublic CompanysugarBEAT non-invasive CGM,proBEAT wellness and coaching programs,Diabetes prevention and reversal services,
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, the company operates as a major provider of healthcare services across the nation.

    ABBOTT LABORATORIES

    Abbott Laboratories is a public company founded in 1888 and based in the United States. With 115,000 employees, it operates as a diversified healthcare and diagnostics company with a global presence.

    DEXCOM, INC.

    Dexcom, Inc. is a publicly traded company founded in 1999 and headquartered in the United States. The company employs 11,050 people and specializes in continuous glucose monitoring technology.

    MEDTRONIC

    Medtronic is a public company founded in 1949 and based in Ireland. With 95,000 employees, it is a global leader in medical technology and device manufacturing.

    SINOCARE

    Sinocare is a publicly traded company founded in 2002 and headquartered in China. The company employs 5,010 people and operates in the healthcare and medical device sector.

    I-SENS, INC.

    I-SENS, Inc. is a publicly traded company founded in 2000 and based in South Korea. The company employs 887 people and operates in the medical device and diagnostics industry.

    NIPRO

    Nipro is a publicly traded company founded in 1947 and based in Japan. With 38,593 employees, it manufactures medical devices and pharmaceutical products for global markets.

    NEMAURA MEDICAL INC.

    Nemaura Medical Inc. is a publicly traded company founded in 2009 and headquartered in the United States. With 36 employees, the company develops wearable medical technology solutions.

    TERUMO CORPORATION

    Terumo Corporation is a publicly traded company founded in 1921 and based in Japan. With 30,591 employees, it manufactures and distributes medical devices and blood products globally.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise valuation data for the UK market (£299.9M in 2025) with accurate forecasts through 2030, enabling confident investment and expansion decisions tailored to the British healthcare landscape.
    • NHS Reimbursement Insights : Understand NHS funding mechanisms, NICE approval pathways, and reimbursement trends specific to blood glucose monitors and CGM devices in the UK healthcare system.
    • Competitive Landscape Analysis : Identify key players, market share distribution, and competitive strategies within the UK blood glucose monitor market to inform product positioning and partnership opportunities.
    • Regulatory & Policy Framework : Gain clarity on UK regulatory requirements, MHRA approval processes, and government digital health initiatives impacting market entry and product commercialization strategies.
    • Growth Driver Identification : Leverage detailed analysis of UK-specific growth factors including aging demographics, diabetes prevalence trends, and NHS investment priorities to identify high-potential market segments.

    Frequently asked questions

    What is the current size of the UK blood glucose monitor market?

    The UK blood glucose monitor market is valued at £299.9 million in 2025 and is expected to grow to £413.9 million by 2030.

    What is the growth rate of the UK blood glucose monitor market?

    The UK blood glucose monitor market is growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2030.

    What are the main drivers of growth in the UK blood glucose monitor market?

    Key drivers include rising diabetes prevalence in the UK, increased NHS investment in digital health, growing adoption of continuous glucose monitoring (CGM) devices, and an aging population with emphasis on preventive care.

    How does the UK market compare to other European markets?

    The UK market is a mature segment within Europe, benefiting from strong regulatory frameworks, established reimbursement pathways, and a digitally engaged patient population that supports steady adoption of advanced glucose monitoring technologies.

    What technologies are driving the UK blood glucose monitor market?

    Continuous glucose monitoring (CGM) devices, remote patient management systems, and digital health integration into NHS protocols are the primary technologies driving market growth in the UK.

    RESEARCH METHODOLOGY

    The study comprised four key activities to estimate the current size of the blood glucose monitor market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step involved validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Top-down and bottom-up approaches were used to arrive at a comprehensive estimate of the overall market size. Finally, market breakdown and data triangulation techniques were utilized to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various secondary sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the blood glucose monitor market. It also helped obtain critical insights about key players in the industry, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, interviews were conducted with various sources from the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts were interviewed, including CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from prominent companies and organizations involved in the blood glucose monitor market. For the demand side, interviews were conducted with industry experts, purchase and sales managers, doctors, and personnel from research organizations. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the blood glucose monitor market is provided below:

    Blood Glucose Monitor Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the blood glucose monitor market includes the following details. The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the blood glucose monitor market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall blood glucose monitor market was obtained from secondary data and validated by primary participants to arrive at the total blood glucose monitor market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall blood glucose monitor market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Blood Glucose Monitor Market Size: Bottom-up Approach and Top-down Approach

    Blood Glucose Monitor Market

    Data Triangulation

    After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    Blood glucose monitors are medical devices used to measure and monitor blood glucose (sugar) levels in individuals, primarily for the diagnosis and management of diabetes mellitus. These monitors help patients and healthcare professionals assess glycemic control, adjust treatment plans, and prevent diabetes-related complications.

    Stakeholders

    • Blood Glucose Monitor Manufacturers
    • Contract Manufacturers
    • Suppliers and Distributors of Blood Glucose Monitors
    • Senior Management
    • Finance Department
    • Healthcare Services Providers (Hospitals and Public & Private Clinics)
    • Academic & Research Institutes
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyze, and forecast the global blood glucose monitor market by product type, application, test site, end user, and region.
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the blood glucose monitor market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
    • To profile the key players in the blood glucose monitor market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product approvals & launches in the blood glucose monitor market.

    Get the Full Blood Glucose Monitor Market Report

    Full forecast, segment splits, and company analysis for all Blood Glucose Monitor Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status